deltatrials
Completed OBSERVATIONAL NCT02250638

Longitudinal Pancreatic Cancer Study

A Prospective Longitudinal Study of CA 19-9 as an Aid in Monitoring Disease in Patients With Pancreatic Cancer

Sponsor: Fujirebio Diagnostics, Inc.

Conditions Pancreatic Cancer
Interventions CA 19-9 Assay
Updated 15 times since 2017 Last updated: Aug 16, 2021 Started: May 31, 2014 Primary completion: Jun 30, 2021 Completion: Jun 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02250638, this observational or N/A phase trial focuses on Pancreatic Cancer and remains completed. Sponsored by Fujirebio Diagnostics, Inc., it has been updated 15 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshot~Mar 2019 – ~Aug 2020 · 17 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Sep 2021 — Dec 2021 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  5. Apr 2021 — Sep 2021 [monthly]

    Active Not Recruiting

▶ Show 10 earlier versions

  1. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting

  2. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  3. Nov 2020 — Dec 2020 [monthly]

    Active Not Recruiting

  4. Aug 2020 — Nov 2020 [monthly]

    Active Not Recruiting

  5. Mar 2019 — Aug 2020 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  6. Jun 2018 — Mar 2019 [monthly]

    Recruiting

  7. May 2018 — Jun 2018 [monthly]

    Recruiting

  8. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  9. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  10. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fujirebio Diagnostics, Inc.
Data source: Fujirebio Diagnostics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations